Birthweight and early-onset type 2 diabetes in American Indians: differential effects in adolescents and young adults and additive effects of genotype, BMI and maternal diabetes.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
09 2019
Historique:
received: 13 02 2019
accepted: 23 04 2019
pubmed: 22 5 2019
medline: 14 4 2020
entrez: 22 5 2019
Statut: ppublish

Résumé

The aim of this work was to estimate the impact of birthweight on early-onset (age <40 years) type 2 diabetes. A longitudinal study of American Indians, aged ≥5 years, was conducted from 1965 to 2007. Participants who had a recorded birthweight were followed until they developed diabetes or their last examination before the age of 40 years, whichever came first. Age- and sex-adjusted diabetes incidence rates were computed and Poisson regression was used to model the effect of birthweight on diabetes incidence, adjusted for sex, BMI, a type 2 diabetes susceptibility genetic risk score (GRS) and maternal covariates. Among 3039 participants, there were 652 incident diabetes cases over a median follow-up of 14.3 years. Diabetes incidence increased with age and was greater in the lowest and highest quintiles of birthweight. Adjusted for covariates, the effect of birthweight on diabetes varied over time, with a non-linear effect at 10-19 years (p < 0.001) and a negative linear effect at older age intervals (20-29 years, p < 0.001; 30-39 years, p = 0.003). Higher GRS, greater BMI and maternal diabetes had additive but not interactive effects on the association between birthweight and diabetes incidence. In this high-risk population, both low and high birthweights were associated with increased type 2 diabetes risk in adolescence (age 10-19 years) but only low birthweight was associated with increased risk in young adulthood (20-39 years). Higher type 2 diabetes GRS, greater BMI and maternal diabetes added to the risk of early-onset diabetes.

Identifiants

pubmed: 31111170
doi: 10.1007/s00125-019-4899-9
pii: 10.1007/s00125-019-4899-9
pmc: PMC6679754
mid: NIHMS1028969
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1628-1637

Subventions

Organisme : Intramural NIH HHS
ID : Z01 DK069000-43
Pays : United States

Références

Lancet Diabetes Endocrinol. 2018 Jan;6(1):69-80
pubmed: 28847479
Diabetes Care. 1980 May-Jun;3(3):458-64
pubmed: 7389563
Diabetologia. 2017 Apr;60(4):645-655
pubmed: 28127622
N Engl J Med. 2017 Jul 20;377(3):301
pubmed: 28723318
JAMA. 2017 Jun 27;317(24):2515-2523
pubmed: 28655017
Diabetes. 2006 Feb;55(2):460-5
pubmed: 16443781
BMJ. 1991 Oct 26;303(6809):1019-22
pubmed: 1954451
JAMA. 2008 Dec 24;300(24):2886-97
pubmed: 19109117
BMJ. 1990 Nov 17;301(6761):1111
pubmed: 2252919
Can J Public Health. 2001 Sep-Oct;92(5):340-4
pubmed: 11702485
Diabetes. 2015 Dec;64(12):4322-32
pubmed: 26246406
Lancet. 1971 Jul 17;2(7716):125-8
pubmed: 4104461
Am J Hum Genet. 1962 Dec;14:353-62
pubmed: 13937884
Diabetes. 2018 May;67(5):1024-1029
pubmed: 29463506
Diabetes. 2015 Jul;64(7):2646-57
pubmed: 25667308
Am J Epidemiol. 2007 Apr 15;165(8):849-57
pubmed: 17215379
Diabetes Care. 2007 Jul;30(7):1758-63
pubmed: 17468358
Diabetes Care. 2003 Feb;26(2):343-8
pubmed: 12547860
Diabetes. 2000 Mar;49(3):445-9
pubmed: 10868967
Lancet. 1999 May 22;353(9166):1789-92
pubmed: 10348008
Diabetes. 2017 Aug;66(8):2284-2295
pubmed: 28476931
Diabet Med. 1998 Mar;15(3):220-7
pubmed: 9545123
Nature. 2016 Oct 13;538(7624):248-252
pubmed: 27680694
BMJ. 2003 Jan 4;326(7379):19-20
pubmed: 12511454
J Diabetes. 2017 Oct;9(10):898-907
pubmed: 27896934
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
Br Med Bull. 2001;60:89-101
pubmed: 11809620
BMJ. 1994 Apr 9;308(6934):942-5
pubmed: 8173400
Diabetologia. 1998 Aug;41(8):904-10
pubmed: 9726592
Diabetes Metab Res Rev. 2013 May;29(4):241-56
pubmed: 23315909
Diabetes. 2013 Aug;62(8):2984-91
pubmed: 23630301
Diabetologia. 1999 Oct;42(10):1265-6
pubmed: 10525671
Arch Pediatr Adolesc Med. 2002 Jul;156(7):651-5
pubmed: 12090830
Diabetes Care. 1999 Jun;22(6):944-50
pubmed: 10372247
Am J Epidemiol. 1978 Dec;108(6):497-505
pubmed: 736028
Diabetologia. 1992 Jul;35(7):595-601
pubmed: 1644236
Diabet Med. 2015 Feb;32(2):220-5
pubmed: 25388749

Auteurs

Muideen T Olaiya (MT)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA. muideen.olaiya@nih.gov.

Lauren E Wedekind (LE)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Robert L Hanson (RL)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.

Madhumita Sinha (M)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.

Sayuko Kobes (S)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.

Robert G Nelson (RG)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.

Leslie J Baier (LJ)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.

William C Knowler (WC)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH